Go Ad-Free
My Alerts
Moneycontrol
Moneycontrol PRO
Get App Open
In App
Lending
Lending
Go PRO Now
Open App
MARKETS

Aurobindo Pharma Ltd.

BSE: 524804 | NSE: AUROPHARMA | Series: | ISIN: INE406A01037 | SECTOR: Pharmaceuticals & Drugs

| BSE 1130.70 -9.85 (-0.86%) | |

BSE Live

Nov 07, 12:01
1130.70 -9.85 (-0.86%)
Volume
AVERAGE VOLUME
5-Day
77,993
10-Day
67,789
30-Day
41,892
6,848

  • Prev. Close

    1140.55

  • Open Price

    1142.00

  • Bid Price (Qty.)

    1130.05 (15)

  • Offer Price (Qty.)

    1131.30 (15)

NSE Live

(%)
Volume
No Data Available

  • Prev. Close

  • Open Price

  • Bid Price (Qty.)

    ()

  • Offer Price (Qty.)

    ()

Aurobindo Pharma is not listed on NSE

Financials

Cash Flow of Aurobindo Pharma (in Rs. Cr.) Mar 25 Mar 24 Mar 23 Mar 22 Mar 21  
  12 mths 12 mths 12 mths 12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 5,066.29 4,379.99 2,612.50 3,372.74 7,343.59  
Net CashFlow From Operating Activities 3,924.62 2,434.52 2,386.75 5,016.48 3,328.92  
Net Cash Used In Investing Activities -1,875.80 -4,255.95 -3,977.75 -3,211.56 598.69  
Net Cash Used From Financing Activities 119.78 800.42 1,814.41 -2,969.27 -1,364.81  
Foreign Exchange Gains / Losses 9.10 14.17 -0.06 0.20 -2.12  
Adjustments On Amalgamation Merger Demerger Others 0.66 0.00 6.41 -3.25 22.41  
Net Inc/Dec In Cash And Cash Equivalents 2,178.36 -1,006.84 229.76 -1,167.40 2,583.09  
Cash And Cash Equivalents Begin of Year 3,385.43 4,392.27 4,162.51 5,329.91 2,746.82  
Cash And Cash Equivalents End Of Year 5,563.79 3,385.43 4,392.27 4,162.51 5,329.91  
Source : Dion Global Solutions Limited

Results of Aurobindo Pharm

Results of Pharmaceuticals Sector

Quick links

News

Corporate Action

Information

Financials

Annual Report

Peer Comparison

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347